Developer docs
API playgroundTry for free, no card

Search company profiles

City Hill Ventures

Full company profile

uuid000dafy

Namestring
City Hill Ventures
Legal namestring
City Hill Ventures, LLC
Company typeenum
Private
Founded yearint
2010
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSan Diego, United States
HQ citystring
San Diego
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
venture capital investing, healthcare venture capital, biotechnology investments, cleantech investments, venturepreneurs investing
Industry1 code
PRIMARYFSANAAAD
Sector-Focused Venture Capital (Vertical Specialists)
NAICS code2 codes
  • Other Financial Vehicles52599
  • Other Investment Pools and Funds5259
Product category
Venture Capital / Private Equity Investing
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Fund Management and Investment Returns
TypeLicensing Royalties
Description

Generates returns through venture capital fund management and equity investment returns from portfolio companies in healthcare, cleantech, and media & entertainment sectors. Fund I achieved DPI of 11 in first seven years. Investment sizes range from $100,000 to $20 million per company.

cityhill.com
Cost components2 values
Personnel, Operations
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

City Hill Ventures is a San Diego-based venture capital firm that deploys capital into private and public companies in biotechnology, healthcare, cleantech, and media & entertainment via two funds. Fund I (City Hill Venture Partners I, LLC) is a healthcare-only fund that made nine investments between 2011 and 2015, while Fund II (City Hill, LLC) is an evergreen fund that invests in biotechnology, cleantech, and media & entertainment. The firm employs a "Found, Fund and Lead" venturepreneur approach, providing capital, company formation, and active operational/advisory leadership to a small number of portfolio companies, with investment sizes ranging from $100,000 to $20 million.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

City Hill Ventures is a venture capital firm operating as a single platform with two distinct investment funds. Fund I (City Hill Venture Partners I, LLC) is a healthcare-focused fund that completed nine investments between 2011-2015. Fund II (City Hill, LLC) is an evergreen fund that has expanded scope to include biotechnology, cleantech, and media & entertainment industries. The firm operates under a 'venturepreneurs' approach, combining Found, Fund, and Lead strategies to maximize value in portfolio companies.

Product and service2 records
1Fund I (City Hill Venture Partners I, LLC)
CategoryVenture Capital Fund
Description

Health care-only venture capital fund that deployed capital into nine healthcare investments between 2011 and 2015, generating a DPI of 11 in its first seven years. Targeted private and public healthcare companies seeking capital and active operational support.

2Fund II (City Hill, LLC)
CategoryVenture Capital Fund
Description

Evergreen venture capital fund that actively invests in private and public companies in biotechnology, cleantech, and media & entertainment, with investment sizes ranging from $100,000 to $20 million per company.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Healthcare-focused venture capital firm also headquartered in San Diego with deep biotech investing heritage. Same metro, same sector vertical, and overlapping LP relationships make it the closest direct peer.

TypeDirect peer
Description

Long-standing biotech and healthcare venture firm with hands-on company-building approach similar to City Hill's Found/Fund/Lead methodology. Operates at larger scale but applies the same operational-investor model in life sciences.

TypeDirect peer
Description

San Diego-based early-stage venture firm historically focused on biotech and healthcare. Directly comparable geography, stage, and sector focus to City Hill Ventures' healthcare/biotech mandate.

TypeBroad incumbent
Description

Large multi-stage venture firm with a meaningful healthcare and biotech practice. Overlaps in healthcare venture investing but operates across many sectors and at much larger scale than City Hill.

TypeDirect peer
Description

Life sciences-focused venture firm investing in biotech and specialty pharma companies. Comparable sector specialization and early-to-growth stage mandate; similar firm profile to City Hill.

TypeBroad incumbent
Description

Large, diversified healthcare investment platform spanning venture, growth, and public equities across biopharma, medtech, and diagnostics. Operates broadly in the same healthcare vertical but at much greater scale and across all stages.

TypeDirect peer
Description

Healthcare-specialist venture firm investing across biotechnology, medical devices, and pharma across stages. Compares on sector focus and stage (early to growth healthcare), though larger AUM and broader geography.

TypeDirect peer
Description

Dedicated healthcare venture and growth firm investing across biopharma and medical devices. Comparable sector specialization and operational involvement, though broader stage range and larger fund sizes.

TypeDirect peer
Description

Early-stage venture firm focused exclusively on life sciences with company-building involvement in portfolio companies. Mirrors City Hill's biotech focus, operational hands-on style, and early-stage orientation.

TypeDirect peer
Description

Early-stage life sciences venture firm that partners with entrepreneurs to build biotech companies. Directly mirrors City Hill's Found/Fund/Lead operational-investing model in the same biotech vertical.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment22 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

City Hill Ventures

Venture Capital / Private Equity Investingcityhillventures.com

City Hill Ventures firmographics

Firmographics
Name
City Hill Ventures
Legal name
City Hill Ventures, LLC
Website
https://cityhillventures.com
Company type
Private
Founded year
2010
Operating status
Operating
Headcount range
1–10 employees
Ownership category
akta.pro rank

City Hill Ventures industry classification

Industry
Product category
Venture Capital / Private Equity Investing
NAICS
Other Financial Vehicles (52599), Other Investment Pools and Funds (5259)
akta.pro industry
PRIMARYFSANAAAD
Sector-Focused Venture Capital (Vertical Specialists)

Keywords

  • Venture capital investing
  • Healthcare venture capital
  • Biotechnology investments
  • Cleantech investments
  • Venturepreneurs investing

Where City Hill Ventures is headquartered

Location

Headquarters

HQ city
San Diego
HQ country
United States
HQ region
North America

Offices1 record

Markets served

City Hill Ventures business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations

Revenue model

  1. Fund Management and Investment Returns: Generates returns through venture capital fund management and equity investment returns from portfolio companies in healthcare, cleantech, and media & entertainment sectors. Fund I achieved DPI of 11 in first seven years. Investment sizes range from $100,000 to $20 million per company.

Go-to-market motion1 record

City Hill Ventures product offering

Product offering

Core offering

City Hill Ventures is a San Diego-based venture capital firm that deploys capital into private and public companies in biotechnology, healthcare, cleantech, and media & entertainment via two funds. Fund I (City Hill Venture Partners I, LLC) is a healthcare-only fund that made nine investments between 2011 and 2015, while Fund II (City Hill, LLC) is an evergreen fund that invests in biotechnology, cleantech, and media & entertainment. The firm employs a "Found, Fund and Lead" venturepreneur approach, providing capital, company formation, and active operational/advisory leadership to a small number of portfolio companies, with investment sizes ranging from $100,000 to $20 million.

Product overview

City Hill Ventures is a venture capital firm operating as a single platform with two distinct investment funds. Fund I (City Hill Venture Partners I, LLC) is a healthcare-focused fund that completed nine investments between 2011-2015. Fund II (City Hill, LLC) is an evergreen fund that has expanded scope to include biotechnology, cleantech, and media & entertainment industries. The firm operates under a 'venturepreneurs' approach, combining Found, Fund, and Lead strategies to maximize value in portfolio companies.

Differentiator

Problem solved

Functional benefit

Products and services

  • Fund I (City Hill Venture Partners I, LLC) Health care-only venture capital fund that deployed capital into nine healthcare investments between 2011 and 2015, generating a DPI of 11 in its first seven years. Targeted private and public healthcare companies seeking capital and active operational support.
  • Fund II (City Hill, LLC) Evergreen venture capital fund that actively invests in private and public companies in biotechnology, cleantech, and media & entertainment, with investment sizes ranging from $100,000 to $20 million per company.

Companies that use City Hill Ventures

Customer profile

Segments1 record

Ideal customer profiles1 record

City Hill Ventures technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

City Hill Ventures partnerships and signals

Strategic signal

Scale indicators5 records

Recent moves4 records

Expansion highlights3 records

City Hill Ventures competitors and assessment

Company assessment

Direct peers

  • Domain Associates: Healthcare-focused venture capital firm also headquartered in San Diego with deep biotech investing heritage. Same metro, same sector vertical, and overlapping LP relationships make it the closest direct peer.
  • ARCH Venture Partners: Long-standing biotech and healthcare venture firm with hands-on company-building approach similar to City Hill's Found/Fund/Lead methodology. Operates at larger scale but applies the same operational-investor model in life sciences.
  • Avalon Ventures: San Diego-based early-stage venture firm historically focused on biotech and healthcare. Directly comparable geography, stage, and sector focus to City Hill Ventures' healthcare/biotech mandate.
  • Pappas Capital: Life sciences-focused venture firm investing in biotech and specialty pharma companies. Comparable sector specialization and early-to-growth stage mandate; similar firm profile to City Hill.
  • Versant Ventures: Healthcare-specialist venture firm investing across biotechnology, medical devices, and pharma across stages. Compares on sector focus and stage (early to growth healthcare), though larger AUM and broader geography.
  • Frazier Healthcare Partners: Dedicated healthcare venture and growth firm investing across biopharma and medical devices. Comparable sector specialization and operational involvement, though broader stage range and larger fund sizes.
  • 5AM Ventures: Early-stage venture firm focused exclusively on life sciences with company-building involvement in portfolio companies. Mirrors City Hill's biotech focus, operational hands-on style, and early-stage orientation.
  • Atlas Venture: Early-stage life sciences venture firm that partners with entrepreneurs to build biotech companies. Directly mirrors City Hill's Found/Fund/Lead operational-investing model in the same biotech vertical.

Broad incumbents

  • New Enterprise Associates (NEA): Large multi-stage venture firm with a meaningful healthcare and biotech practice. Overlaps in healthcare venture investing but operates across many sectors and at much larger scale than City Hill.
  • OrbiMed: Large, diversified healthcare investment platform spanning venture, growth, and public equities across biopharma, medtech, and diagnostics. Operates broadly in the same healthcare vertical but at much greater scale and across all stages.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

City Hill Ventures social profiles

Digital presence

City Hill Ventures financial estimates

Financial estimate

Revenue estimate

Valuation estimate

City Hill Ventures leadership team

Management profile

Number of profiles

Profiles2 records

City Hill Ventures funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

City Hill Ventures M&A and investment

M&A and investment

M&A

Investments22 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about City Hill Ventures

What does City Hill Ventures do?

City Hill Ventures is a San Diego-based venture capital firm that deploys capital into private and public companies in biotechnology, healthcare, cleantech, and media & entertainment via two funds. Fund I (City Hill Venture Partners I, LLC) is a healthcare-only fund that made nine investments between 2011 and 2015, while Fund II (City Hill, LLC) is an evergreen fund that invests in biotechnology, cleantech, and media & entertainment. The firm employs a "Found, Fund and Lead" venturepreneur approach, providing capital, company formation, and active operational/advisory leadership to a small number of portfolio companies, with investment sizes ranging from $100,000 to $20 million.

Is City Hill Ventures a public or private company?

City Hill Ventures is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was City Hill Ventures founded?

City Hill Ventures was founded in 2010. It employs 1 to 10 people.

Where is City Hill Ventures based?

City Hill Ventures is headquartered in San Diego, United States, in the North America region.

How does City Hill Ventures make money?

One revenue line is on record: fund Management and Investment Returns.

Who are City Hill Ventures's main competitors?

Direct peers on record are Domain Associates, ARCH Venture Partners, Avalon Ventures, Pappas Capital, Versant Ventures, Frazier Healthcare Partners, 5AM Ventures and Atlas Venture. Broad incumbents are New Enterprise Associates (NEA) and OrbiMed.

Does City Hill Ventures have an API?

No public API is recorded for City Hill Ventures.

What industry is City Hill Ventures in?

City Hill Ventures's product category is Venture Capital / Private Equity Investing. Its primary akta.pro industry code is FSANAAAD, Sector-Focused Venture Capital (Vertical Specialists). Its NAICS code is 52599.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FinSMEsMaze Therapeutics Receives Investment from City Hill VenturesMaze Therapeutics received an undisclosed investment from City Hill Ventures, with Dr. Jonathan Lim joining its board. The company, led by CEO Jason Coloma, develops therapeutic candidates for genetically defined diseases. Maze was launched in 2019 with funding from multiple investors.FinSMEsBonti Closes $15.5M Series C FundingBonti, a clinical-stage biotechnology company, closed a $15.5M Series C financing led by City Hill Ventures. The company, which has raised over $36M to date, will use the funds to continue developing its botulinum neurotoxin EB-001 and support ongoing pain studies. David Ramsay was appointed CFO.FinSMEsIgnyta Closes $5.5M Series B Equity Financing; Receives $500K Loans from SVBIgnyta closed an expanded $5.5M Series B equity financing, led by City Hill Ventures, and received a $500K capital term loan from Silicon Valley Bank. The company will use the funds to advance its Enlyta diagnostic assays toward commercialization and prepare for CLIA certification, targeting late 2014 or early 2015.VC News DailyNexDx Raises $2.6M in Series BNexDx, Inc., a San Diego-based molecular diagnostics company focused on rheumatoid arthritis and autoimmune diseases, announced the successful closing of a $2.1 million Series B financing led by City Hill Ventures, along with a $500,000 capital term loan from Silicon Valley Bank. The combined $2.6 million in new funding will support ongoing research and development and advance the company's lead molecular diagnostic test for rheumatoid arthritis into analytical and clinical validation. According to NexDx's Chairman and CEO, the financing represents validation of the company's approach to transforming biomarkers and diagnostic tests for rheumatologists, patients, and biopharmaceutical companies.VC News DailyIndependa Completes $1.8M Equity and Debt RoundTelehealth innovator Independa, Inc. has closed a seed funding round raising $1.6 million in equity from private investors and venture capital firms Miramar Venture Partners and City Hill Ventures, along with $200,000 in debt financing from Silicon Valley Bank. The San Diego-based company, which provides technology-enabled products for elderly care, plans to use the funds to support product development, build market-distribution channels, and launch pilot programs. Current investors have authorized raising an additional $600,000 due to strong interest from other potential investors.